306 related articles for article (PubMed ID: 21181319)
1. Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding.
Kuipers EJ; Sung JJ; Barkun A; Mössner J; Jensen D; Stuart R; Lau JY; Ahlbom H; Lind T; Kilhamn J
Adv Ther; 2011 Feb; 28(2):150-9. PubMed ID: 21181319
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy.
Sung JJ; Suen BY; Wu JC; Lau JY; Ching JY; Lee VW; Chiu PW; Tsoi KK; Chan FK
Am J Gastroenterol; 2014 Jul; 109(7):1005-10. PubMed ID: 24777150
[TBL] [Abstract][Full Text] [Related]
3. Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of Peptic Ulcer Bleed study.
Sung JJ; Mössner J; Barkun A; Kuipers EJ; Lau J; Jensen D; Stuart R; Junghard O; Olsson G;
Aliment Pharmacol Ther; 2008 Apr; 27(8):666-77. PubMed ID: 18248654
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer.
Yamada S; Wongwanakul P
J Med Assoc Thai; 2012 Mar; 95(3):349-57. PubMed ID: 22550833
[TBL] [Abstract][Full Text] [Related]
5. Double oral esomeprazole after a 3-day intravenous esomeprazole infusion reduces recurrent peptic ulcer bleeding in high-risk patients: a randomised controlled study.
Cheng HC; Wu CT; Chang WL; Cheng WC; Chen WY; Sheu BS
Gut; 2014 Dec; 63(12):1864-72. PubMed ID: 24658598
[TBL] [Abstract][Full Text] [Related]
6. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial.
Sung JJ; Barkun A; Kuipers EJ; Mössner J; Jensen DM; Stuart R; Lau JY; Ahlbom H; Kilhamn J; Lind T;
Ann Intern Med; 2009 Apr; 150(7):455-64. PubMed ID: 19221370
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.
Liu N; Liu L; Zhang H; Gyawali PC; Zhang D; Yao L; Yang Y; Wu K; Ding J; Fan D
J Gastroenterol Hepatol; 2012 Sep; 27(9):1473-9. PubMed ID: 22646140
[TBL] [Abstract][Full Text] [Related]
8. Intravenous Esomeprazole for Prevention of Peptic Ulcer Rebleeding: A Randomized Trial in Chinese Patients.
Bai Y; Chen DF; Wang RQ; Chen YX; Shi RH; Tian DA; Chen H; Eklund S; Li ZS;
Adv Ther; 2015 Nov; 32(11):1160-76. PubMed ID: 26581750
[TBL] [Abstract][Full Text] [Related]
9. Esomeprazole for the treatment of peptic ulcer bleeding.
den Hoed CM; Kuipers EJ
Expert Rev Gastroenterol Hepatol; 2010 Dec; 4(6):679-95. PubMed ID: 21108587
[TBL] [Abstract][Full Text] [Related]
10. Effect of oral esomeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.
Wei KL; Tung SY; Sheen CH; Chang TS; Lee IL; Wu CS
J Gastroenterol Hepatol; 2007 Jan; 22(1):43-6. PubMed ID: 17201879
[TBL] [Abstract][Full Text] [Related]
11. Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities.
Cheng HC; Chang WL; Yeh YC; Chen WY; Tsai YC; Sheu BS
Gastrointest Endosc; 2009 Sep; 70(3):433-9. PubMed ID: 19500787
[TBL] [Abstract][Full Text] [Related]
12. Peptic ulcer bleeding following therapeutic endoscopy: a new indication for intravenous esomeprazole.
Baker DE
Rev Gastroenterol Disord; 2009; 9(4):E111-8. PubMed ID: 20065918
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A
Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754
[TBL] [Abstract][Full Text] [Related]
14. Comparison of infusion or low-dose proton pump inhibitor treatments in upper gastrointestinal system bleeding.
Songür Y; Balkarli A; Acartürk G; Senol A
Eur J Intern Med; 2011 Apr; 22(2):200-4. PubMed ID: 21402254
[TBL] [Abstract][Full Text] [Related]
15. Phase I, multicenter, randomized, open-label study evaluating the pharmacokinetics and safety profile of repeated once-daily doses of intravenous esomeprazole in children 0 to 17 years of age.
Sandström M; Davidson G; Tolia V; Sullivan JE; Långström G; Lundborg P; Brown K
Clin Ther; 2012 Aug; 34(8):1828-38. PubMed ID: 22832034
[TBL] [Abstract][Full Text] [Related]
16. Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial.
Jensen DM; Eklund S; Persson T; Ahlbom H; Stuart R; Barkun AN; Kuipers EJ; Mössner J; Lau JY; Sung JJ; Kilhamn J; Lind T
Am J Gastroenterol; 2017 Mar; 112(3):441-446. PubMed ID: 28094314
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of high-dose intravenous esomeprazole for peptic ulcer bleeding.
Barkun AN; Adam V; Sung JJ; Kuipers EJ; Mössner J; Jensen D; Stuart R; Lau JY; Nauclér E; Kilhamn J; Granstedt H; Liljas B; Lind T
Pharmacoeconomics; 2010; 28(3):217-30. PubMed ID: 20151726
[TBL] [Abstract][Full Text] [Related]
18. Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial.
Lanas A; Polo-Tomas M; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Calvet X; Feu F; Perez-Aisa A; Sung JJ
Scand J Gastroenterol; 2013 Mar; 48(3):285-94. PubMed ID: 23298283
[TBL] [Abstract][Full Text] [Related]
19. Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial.
Messmann H; Schaller P; Andus T; Lock G; Vogt W; Gross V; Zirngibl H; Wiedmann KH; Lingenfelser T; Bauch K; Leser HG; Schölmerich J; Holstege A
Endoscopy; 1998 Sep; 30(7):583-9. PubMed ID: 9826134
[TBL] [Abstract][Full Text] [Related]
20. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
